Showing 41 - 50 of 50 results filtered by

Filter results
× Clear filters

    Rheumatoid Arthritis Conditions

    Biological therapies include adalimumab, certolizumab pegol, etanercept , golimumab, infliximab, anakinra, abatacept, rituximab and tocilizumab. They are called biological medicines becau...

    Psoriasis Conditions

    For example, methotrexate , ciclosporin , acitretin , etanercept , infliximab, efalizumab, ustekinumab and adalimumab. There is some risk of serious side-effects with these medicines, so ...

    Joint Injection and Aspiration Professional

    Radioisotopes. Infliximab. There is some evidence to suggest intra-articular hyaluronic acid is effective and gives more prolonged pain relief than intra-articular corticosteroids. [ 5 ...

    Kawasaki Disease Professional

    Anti-tumour necrosis factor (anti-TNF)-alpha therapies: Infliximab (monoclonal antibody acting as TNF-alpha antagonist). [ 12 ] Etanercept (a soluble TNF-alpha receptor). [ 13 ] ...

    Juvenile Idiopathic Arthritis Professional

    It is the only anti-TNF licensed in the UK for JIA. [ 10 ] Tocilizumab is approved by the National Institute for Health and Care Excellence (NICE) for treatment of systemic JIA when steroids and m...

    Sarcoidosis Professional

    Although lupus pernio lesions usually improve with corticosteroid therapy, these lesions usually require infliximab therapy for significant resolution. Joint Non-steroidal anti-inflam...

    Ankylosing Spondylitis Professional

    Golimumab has recently been recommended by NICE on a similar basis [ 13 ] . Infliximab is not recommended. The NICE recommendations concerning etanercept and adalimumab were published...

    Tuberculosis Professional

    Rates of such concurrent infections in the UK are proportionally low but at least 3% of people with TB are HIV-positive. [ 3 ] Patients on immunosuppressant drugs are particularly at risk (eg, inf...

    Systemic Sclerosis (Scleroderma) Professional

    Pharmacological options that have been tried include aluminium hydroxide, bisphosphonates, calcium-channel blockers, colchicine, infliximab, IV immunoglobulin, minocycline, rituximab and warf...

    Uveitis Professional

    Biologics, which target mediators of the inflammation cascade, may offer the potential to provide more effective and less toxic treatment. [ 15 ] Ongoing research is examining the use of immune mo...